1.
- Combination therapy of lapatinib and Capecitabine for ErbB2-positive metastatic or locally advanced breast cancer: results from the Lapatinib Expanded Access Program (LEAP) in Central and Eastern Europe. Onkológia. - ISSN 1336-8176. - Roč. 6, č. 5 (2011), s. 310-311
- C 3069